Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31 results about "Blood supplying" patented technology

The volume of blood supplied to an organ or part during a particular time period. Usually a subjective estimate by a surgeon in determining whether the blood supply is adequate to maintain viability.

Blood thrombus and embolus resectoscope

The invention discloses an intravascular thrombus and embolus resectoscope. The technique problem to be solved is that while thrombus and embolus are taken out, the distal end of a blood vessel cavity is protected. The intravascular thrombus and embolus resectoscope is provided with a thrombus resectoscope. The thrombus resectoscope comprises a basket with netting on top which shows shrinkage or releasing state and is arranged on the distal end of the thrombus resectoscope. A guide bar is connected with the basket with netting at the same axis; the distal end of the guide bar is connected with a soft guide wire head; when the basket with netting on top shows shrinkage or releasing state, the whole thrombus resectoscope is arranged in a delivery pipeline which is arranged in a recovery pipeline and can extends towards the distal end along the recovery pipeline. Compared with the existing technique, the blood stream of the blood vessel can continuously flow in the process of the capturing, winding, and extraction of the thrombus; the invention does not interface the blood supplying of the normal brain issue and protects the distal end of the cavity of the blood vessel; all gore or thrombus chips generated from the extraction process of the thrombus and embolus can be taken out.
Owner:APT MEDICAL HUNAN INC

Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation

InactiveUS20040010307A1Easy constructionLow costStentsBlood vesselsImplanted deviceArterial bifurcation
A device implantable in an artery at a bifurcation into a first branch supplying blood to a vital region having a high sensitivity to emboli in the blood, and a second branch supplying blood to a less vital region having a lower sensitivity to emboli in the blood. The implantable device is initially of a small diameter for facilitating its introduction into and deployment through the artery to the bifurcation, and is expandable to a larger diameter for implantation in the artery at the bifurcation. The implantable device includes a base element for anchoring in the artery at the bifurcation; and a deflector element for covering the inlet of the first branch at the bifurcation. The deflector element is formed with openings of a size and configuration to deflect emboli in the blood to the second branch without blocking blood flow through the second branch or through the first branch. The base element is a coil of tubular configuration having overlapping ends enabling it to be expanded from the initial diameter to the larger diameter. In the described preferred embodiments, the device is configured and dimensioned for implantation in the CCA at its bifurcation into the ICA and ECA.
Owner:SURPASS MEDICAL

Method and Apparatus for Treatment of Congestive Heart Disease

In one aspect, the present invention is directed to an apparatus and method for treating congestive heart failure that restores kidney renal functions by artificial perfusion of at least one kidney. In one aspect, a catheter inserted into the aorta of the patient has an outlet port that supplies the patient's blood obtained from a patient's aorta into an adjoining renal artery of the patient to perfuse the kidney. The catheter comprises a rotor housed inside a portion of the catheter to supply the blood to the kidney at a desired pressure. The restoration of kidney function assists the heart by removing excess fluid, urine and toxin from the patient, and by normalizing the patient's renin-angiotensin system and other neurohormonal substances.
Owner:PATEL VINOD

Electroporation to deliver chemotherapeutics and enhance tumor regression

A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and / or infusion of a material such as a chemotherapeutic agent or marker into the blood.
Owner:RGT UNIV OF CALIFORNIA

Electroporation to deliver chemotherapeutics and enhance tumor regression

ActiveUS8298222B2Disruption in blood flowReducing minimal therapeutic doseElectrotherapySurgical needlesCell membraneTumor regression
A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and / or infusion of a material such as a chemotherapeutic agent or marker into the blood.
Owner:RGT UNIV OF CALIFORNIA

Methods and compositions for tissue regeneration

InactiveUS20060121002A1Reestablish integrityInhibit excessive scar formationPeptide/protein ingredientsGenetic material ingredientsCell-Extracellular MatrixInjury mouth
The present invention provides the use and composition of matter of angiogenic or other growth / cytokine factors expressed by mixtures of allogeneic human cell strains or lines of various types and stages of differentiation. Also provided are unencapsulated preparations (mixed with or applied to extracellular matrix material or synthetic biocompatible substances) for the purpose of temporary application to wounds or defects in the skin or other tissues for the restoration of blood supplying connective tissue to enable organ-specific cells to reestablish organ integrity as well as to inhibit excessive scar formation.
Owner:SMITH & NEPHEW INC

Methods and compositions for tissue regeneration

The present invention provides the use and composition of matter of angiogenic or other growth / cytokine factors expressed by mixtures of allogeneic human cell strains or lines of various types and stages of differentiation. Also provided are unencapsulated preparations (mixed with or applied to extracellular matrix material or synthetic biocompatible substances) for the purpose of temporary application to wounds or defects in the skin or other tissues for the restoration of blood supplying connective tissue to enable organ-specific cells to reestablish organ integrity as well as to inhibit excessive scar formation.
Owner:SMITH & NEPHEW INC

Method and coupling apparatus for facilitating an vascular anastomoses

InactiveUS7008436B2Fast and uniform methodTiming inconsistencySuture equipmentsSurgical staplesVascular anastomosisSaphenous veins
The present invention, which addresses the needs described above, resides in an apparatus and method for coupling vascular apertures to a blood supply vessel in a manner that minimizes the time and operator dependent inconsistency in performing vascular anastomoses. In the coronary setting, this concept is fast and can be applied to both conventional and minimally invasive operative techniques. In the preferred embodiment, the present invention relates to an apparatus and method for facilitating end-to-side vascular anastomoses procedure, whereby the present invention acts as a coupling apparatus between a first, blood supplying hollow organ, e.g. the LIMA, radial artery, or a saphenous vein and the side wall of second hollow organ, typically one of the major coronary arteries, such as the left coronary artery (LCA), right coronary artery (RCA) or the circumflex (CX).
Owner:BARATH PETER

Liver image segregation method based on hierarchy vessel tree division

The invention relates to a liver image segregation method based on hierarchy vessel tree division. The method comprises the steps that firstly, a directed tree is utilized to represent a topological structure of a liver portal vein vessel, then according to space distribution and branch average radius information of the liver portal vein vessel in a specific clinical case image, vessel hierarchical parameters are determined and a hierarchical vessel tree is created, a second-level subtree set providing blood for a liver is marked, marked second-level subtrees are divided into eight kinds according to blood supplying areas, the liver is divided into eight hepatic segments through the adoption of the shortest distance algorithm to be analyzed, and clinical interesting information is extracted. According to the method, for liver vessels with multiple branches and complex structures, good hieratical effects can be obtained, blood supplying effects of most second-level branches are considered, and hepatic segment distribution and attribute information obtained through segregation also accord with the Couinaud hepatic segmentation theory.
Owner:TONGJI UNIV

Free skin flap in-vitro distal blood supplying device

ActiveCN104096274ABlood circulation temperatureGuaranteed uptimeSuction devicesPeristaltic pumpGuide tube
The invention provides a free skin flap in-vitro distal blood supplying device, and relates to the field of mechanical instruments. The free skin flap in-vitro distal blood supplying device comprises an artery blood supplying unit, a vein blood returning unit, a precise peristaltic pump, a blood anti-freezing device and a temperature control system, wherein the artery blood supplying unit comprises an artery puncture needle, a blood delivery catheter, a flow adjuster, a three-way pipe, a skin flap artery anastomosis needle and an elastic sleeve; the vein blood returning unit comprises a vein puncture needle, a blood delivery catheter, a catheter joint, a three-way pipe, a peristaltic pump pipe, a skin flap vein anastomosis needle and an elastic sleeve; the temperature control system comprises a circulating water pump, a water delivery catheter, a heating catheter and a constant-temperature water tank; the peristaltic pump is precise and is suitable for pumping liquid with medium and small flow; the blood anti-freezing device is a precise injection pump filled with anticoagulant normal saline; and anticoagulant is injected into the artery blood supplying device through a catheter. The free skin flap in-vitro distal blood supplying device is used for distally and continuously supplying blood for free skin flaps circularly in a free skin flap surgery; and the problem that good blood supplying vessels do not exist surrounding a skin flap area is solved.
Owner:SOUTHEAST UNIV

Blood thrombus and embolus resectoscope

The invention discloses an intravascular thrombus and embolus resectoscope. The technique problem to be solved is that while thrombus and embolus are taken out, the distal end of a blood vessel cavity is protected. The intravascular thrombus and embolus resectoscope is provided with a thrombus resectoscope. The thrombus resectoscope comprises a basket with netting on top which shows shrinkage or releasing state and is arranged on the distal end of the thrombus resectoscope. A guide bar is connected with the basket with netting at the same axis; the distal end of the guide bar is connected with a soft guide wire head; when the basket with netting on top shows shrinkage or releasing state, the whole thrombus resectoscope is arranged in a delivery pipeline which is arranged in a recovery pipeline and can extends towards the distal end along the recovery pipeline. Compared with the existing technique, the blood stream of the blood vessel can continuously flow in the process of the capturing, winding, and extraction of the thrombus; the invention does not interface the blood supplying of the normal brain issue and protects the distal end of the cavity of the blood vessel; all gore or thrombus chips generated from the extraction process of the thrombus and embolus can be taken out.
Owner:APT MEDICAL HUNAN INC

Far infrared magnet therapy paster for treating tumor

The invention relates to the field of medical treatment, in particular to a far infrared magnet therapy paster for treating the tumor. The far infrared magnet therapy paster comprises medical adhesive tape, a far infrared magnet therapy layer, a protection layer and the like, and has different magnetic field intensities, different shapes and different specifications and models. The far infrared magnet therapy paster has the functions of restraining tumor tissue blood supplying and metabolism, changing cancer cell forms, inducing tumor cell apoptosis, restraining tumor growth, enabling the tumor to gradually become smaller, eliminating the inflammation of the vascular wall, reducing pain signal transmission, controlling middle and late period cancer diffusion and pains, improving local microcirculation and immunity and not hurting the benign adjustment of the normal cells. When the far infrared magnet therapy paster is used, the specifications and models are selected according to the ages, the states of illness and the nidus positions, the protection layer is uncovered, the far infrared magnet therapy layer of the paster tightly adheres to the channel and collateral skin in the nidus area and the related shu-acupoint or Shenque acupoint, a plurality of pasters can be used at different positions at the same time, and the paster is replaced every one to two days.
Owner:罗世琴

Axillary artery cannula for achieving no perfusion ischemic areas during extracorporeal circulation period and application thereof

InactiveCN104208798AAvoid damageShorten ischemic timeCatheterExtracorporeal circulationWhole body
The invention relates to an axillary artery cannula for achieving no perfusion ischemic areas during extracorporeal circulation period and application thereof. The axillary artery cannula comprises a cannula body with a blood supplying end, and is characterized by also comprising a proximal artery tube and a distal artery tube which communicate with the cannula body and play roles in shunting and sharing pressure, thus forming an extracorporeal circulation plastic perfusion tube of which the whole structure is T-shaped or Y-shaped, wherein an included angle is reserved between the proximal artery tube of the perfusion tube with Y-shaped structure and the cannula body of the blood supplying end to distribute and adjust blood flow volume of perfusion. The axillary artery cannula is applied to a right axillary artery to achieve systemic arterial perfusion during the extracorporeal circulation period and selective cerebral perfusion during deep hypothermic circulatory arrest, and meanwhile can avoid right upper limb ischemia. Obviously, the axillary artery cannula can meet systemic arterial perfusion during the extracorporeal circulation period and cerebral perfusion during circulatory arrest, can distribute and adjust perfusion blood flow, and achieves no perfusion ischemic areas; and the axillary artery cannula is simple and convenient to operate, easy and reliable to fix, not prone to rising perfusion pressure and causing blood leakage, less in blood damage, greatly shortened in operation time and reduced in right upper limb ischemic time.
Owner:黄晓

Extracorporeal Remote Blood Supply Device for Free Skin Flap

ActiveCN104096274BBlood circulation temperatureGuaranteed uptimeSuction devicesPeristaltic pumpBlood vessel
The invention provides a free skin flap in-vitro distal blood supplying device, and relates to the field of mechanical instruments. The free skin flap in-vitro distal blood supplying device comprises an artery blood supplying unit, a vein blood returning unit, a precise peristaltic pump, a blood anti-freezing device and a temperature control system, wherein the artery blood supplying unit comprises an artery puncture needle, a blood delivery catheter, a flow adjuster, a three-way pipe, a skin flap artery anastomosis needle and an elastic sleeve; the vein blood returning unit comprises a vein puncture needle, a blood delivery catheter, a catheter joint, a three-way pipe, a peristaltic pump pipe, a skin flap vein anastomosis needle and an elastic sleeve; the temperature control system comprises a circulating water pump, a water delivery catheter, a heating catheter and a constant-temperature water tank; the peristaltic pump is precise and is suitable for pumping liquid with medium and small flow; the blood anti-freezing device is a precise injection pump filled with anticoagulant normal saline; and anticoagulant is injected into the artery blood supplying device through a catheter. The free skin flap in-vitro distal blood supplying device is used for distally and continuously supplying blood for free skin flaps circularly in a free skin flap surgery; and the problem that good blood supplying vessels do not exist surrounding a skin flap area is solved.
Owner:SOUTHEAST UNIV

Vaneless blood pump

The invention relates to a vaneless blood pump. The vaneless blood pump comprises a volute, at least one separating piece, a rotor, a diversion piece and a power device; the volute is provided with a first cavity, a first liquid inlet and a first liquid outlet, wherein the first liquid inlet and the first liquid outlet are communicated with the first cavity; the separating piece and the rotor are arranged in the first cavity; the separating piece is provided with a second cavity, a second liquid inlet and a second liquid outlet, wherein the second liquid inlet and the second liquid outlet are communicated with the second cavity; the rotor is sleeved with the separating piece and fixedly connected with the separating piece through the diversion piece; a laminar flow channel is formed between the inner wall of the separating piece and the outer wall of the rotor. By supplying blood in this mode, the blood which needs to be supplied can flow in a laminar flow state, so that phenomena of hemolysis and thrombosis do not occur to the blood easily; meanwhile, the blood is not squeezed in the laminar flow mode, the damage to the blood is relatively small, long-term blood supplying can be conducted, the requirements of long-term blood supplying can be met, and the quality of the blood is ensured.
Owner:GUANGDONG SHUNDE IND DESIGN INST GUANGDONG SHUNDE INNOVATIVE DESIGN INST +1

Use of traditional Chinese medicine in preparing medicine for treating retinal vein obstruction

The invention discloses a traditional Chinese medicine composite which is applied to preparing the medicine for curing retinal vein occlusion. The traditional chinese medicine composite is composed of ginseng, leech, centipede, scorpion, woodlouse, cicada slough, red peony root and borneol and the like, with efficiency of supplementing qi and activating blood circulation and eliminating blood stasis and freeing channels. The traditional chinese medicine composite has the function of osmosis resistance, strengthening the venous constriction, improving the flexibility of the vein wall, and increasing the venous pressure of the blood vessel wall, so as to reach the detumescence and relief purpose for vein blood stasis symptom, alleviate retinal edema and the edema in blood vessels, strengthen retinal artery blood supplying and improve the sight of patients who have retinal vein occlusion. The traditional chinese medicine composite has obvious curative effects on curing the retinal vein occlusion, and the total curative effect ratio which is validated in clinical trials of curing the retinal vein occlusion through the traditional chinese medicine composite can reach 91.9%, with security and simplicity and few adverse effects.
Owner:HEBEI YILING MEDICINE INST

Absorbable tissue closed fixing device

PendingCN108201454AShort healing timeLittle effect on blood supplySuture equipmentsWound healingHuman body
The invention relates to an absorbable tissue closed fixing device, and belongs to the field of medical instruments. The device is made of a biological absorbable material, the device is composed of abase plate 1, a puncture needle 2 and a reverse spine 3, the puncture needle 2 is arranged on the base plate 1, the angle between the base plate 1 and the puncture needle 2 is 45 degrees to 90 degrees, the reverse spine is arranged on the puncture needle 2, and the angle between the reverse spine 3 and the sharp end direction of the puncture needle 2 is greater than or equal to 135 degrees. According to the device, the device is used for sewing up a skin soft tissue wound and potential lacuna and fixing soft tissues and bones during an operation. The device is simple to operate, the influenceof blood supplying on the marginal tissue of the wound is small, the healing time of the wound is short, and the device is made of the biological degradable / biological absorbable material, so that the device is capable of being gradually degraded in a human body and absorbed by the human body.
Owner:LANZHOU UNIVERSITY

Docetaxel-absolute ethyl alcohol tumor embolization agent and preparation method thereof

The invention discloses a docetaxel-absolute ethyl alcohol tumor embolization agent and a preparation method thereof. The raw materials of the tumor embolization agent are composed of docetaxel, sodium alginate and absolute ethyl alcohol. The docetaxel-absolute ethyl alcohol tumor embolization agent and the preparation method thereof have the advantages that the hardening and chemical ablation effects of the absolute ethyl alcohol are utilized to load the antitumor drug docetaxel and self-developed sodium alginate microspheres, and the prepared embolization agent can embolize peripheral bloodvessels, can occlude blood vessels with different apertures and different flow quantities, and is transported easily through a catheter, obtained easily and disinfected easily; antitumor drug-docetaxel can be effectively carried to arrive into tumor blood supplying vessels and slowly released in the local tumor, thereby improving the curative effect of tumor interventional embolization treatment.
Owner:无锡紫杉药业股份有限公司

Protective exoskeleton plaster for cranial bone absence

PendingCN110613530AMonitor and maintain sealAvoid external damageProsthesisAdhesiveIntracranial Hemorrhages
The invention provides a protective exoskeleton plaster for cranial bone absence. The protective exoskeleton plaster comprises an exoskeleton plaster body and an annular double-sided adhesive, whereinthe exoskeleton plaster body is composed of an external surface layer, an exoskeleton plate and a wrapping layer, and an air vent valve is mounted on the exoskeleton plaster body. According to the protective exoskeleton plaster for cranial bone absence, an exoskeleton support can be equipped outside a scalp of a cranial bone absence part, injury to intracranial tissue caused by an external forcecan be withstood, a normal and stable intracranial pressure can be maintained, a normal form of a cranial cavity can be restored, a normal anatomical position of the intracranial tissue is restored, agood protecting and supporting action is exerted, collapse of the intracranial tissue and a ventricular system is avoided, improvement on brain tissue blood supplying and lowering of incidence rate of complications such as intracranial hemorrhage, epilepsy and hydrocephaly are facilitated, favorable conditions are created for a subsequent cranioplasty, and thus, a patient can gain better prognosis.
Owner:郭春梅

Food, health product or pharmaceutical composition with blood enriching effect and preparation method thereof

The invention discloses foodstuff, a health product or a pharmaceutical composition with a blood enriching efficacy. The foodstuff, the health product or the pharmaceutical composition are prepared by the following raw materials in parts by weight: 2.4-3.6 parts of longan pulp, 1.6-2.4 parts of mulberries, 1.6-2.4 parts of Chinese wolfberry fruits, and 1.6-2.4 parts of rubus berries. The composition has a reasonable formula according to a theory of traditional Chinese medicine, and has the efficacies for tonifying kidney which is congenital foundation, and tonifying spleen which is postnatal foundation; the combination can enrich blood in heart and liver, tonify yin of liver and kidney, and mildly regulate cold and heat; qi-blood and yin-yang are considered, tonifying and astringency inducing are considered at the same time, and tonifying strength is reinforced. Efficacy experiments show that four raw materials longan pulp, mulberries, Chinese wolfberry fruits and rubus berries are synergistically interacted, in order to perform substantial blood enriching effects. Furtherly, the four raw materials have homology of medicine and food, and can be further developed into foodstuffs or health products with the blood enriching efficacy and wide market prospects.
Owner:中山瑞德生物科技有限公司

Pharmaceutical composition of melon betel or its extract and safflower or its extract

The present invention belongs to medical technique field, a medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation and application thereof and preparation containing the medicinal composition are disclosed. Constitution of raw material medicine containing medicinal components used for preparing the medicinal composition is: fructus trichosanthis 100 to 2000 shares, safflower 100 to 1500 shares, or is: fructus trichosanthis extraction 2 to 160 shares, safflower yellow pigment 1 to 45 shares. The medicinal composition can be prepared into various pharmaceutically any acceptable preparations, optimizing injection or oral preparation. The medicinal composition of the present invention has effects such as dilating coronary artery, increasing coronary flow, inhibiting thrombocyte coagulation, decreasing blood viscosity, improving hemorheology and microcirculation, reducing thrombosis, improving heart blood-supplying function, decreasing cerebrovascular resistance, increasing cerebrovascular flow, improving brain microcirculation and etc.
Owner:海安江理工技术转移中心有限公司

Liver Image Segmentation Method Based on Hierarchical Vascular Tree Division

The invention relates to a liver image segregation method based on hierarchy vessel tree division. The method comprises the steps that firstly, a directed tree is utilized to represent a topological structure of a liver portal vein vessel, then according to space distribution and branch average radius information of the liver portal vein vessel in a specific clinical case image, vessel hierarchical parameters are determined and a hierarchical vessel tree is created, a second-level subtree set providing blood for a liver is marked, marked second-level subtrees are divided into eight kinds according to blood supplying areas, the liver is divided into eight hepatic segments through the adoption of the shortest distance algorithm to be analyzed, and clinical interesting information is extracted. According to the method, for liver vessels with multiple branches and complex structures, good hieratical effects can be obtained, blood supplying effects of most second-level branches are considered, and hepatic segment distribution and attribute information obtained through segregation also accord with the Couinaud hepatic segmentation theory.
Owner:TONGJI UNIV

Preparation method of magnetic guiding anticancer medicine

InactiveCN100384475CPowder deliveryEnergy modified materialsBlood/plasma substituteThrombus
A magnetically pilotted anticancer medicine is prepared by adding the magnetic Fe-C attachment to the medium containing the blood plasma substitute and anticancer medicine. Under the monitor of angiography, said medicine can be pilotted magnetically in the blood supplying artery of tumor to form thrombus in the blood vessels around the tumor, so fully playing the role of anticancer medicine.
Owner:DEZHOU KELONG CARRIER INST

Medicine cake for treating cervical spondylosis and preparing method thereof

The invention discloses a medicine cake for treating cervical spondylosis. The medicine cake is characterized by being prepared from, by weight, 2 parts of symplocos chinensis, 2 parts of coniogramme japonica, 2 parts of tiger grouper, 1 part of tylophora koi, 1 part of rhizomes of buddleia davidii franch, 1 part of roots of henry currant, 1 part of primula szechuanica, 1 part of the root of cissus rhombifolia, 1 part of japanese ophiorrhiza herb, 1 part of tacca chantrieri andre, 1 part of dallergiahancai benth bark, 1 part of camphor tree bark, 1 part of toddalia asiatualam and 1 part of root-flower of daphne odora thunb. For achieving convenient using and the most suitable treating effect, a preparing method of the medicine cake includes the steps that the fourteen kinds of herbal medicine powder are prepared into medicine powder, and then the medicine cake with the effects of activating blood, dissolving stasis, relieving swelling, removing stasis, dispelling wind and eliminating dampness is modulated through white sugar and boiled water. After the medicine cake is externally applied, the medicine effect can be enduringly acted on the affected part, meridian warming and activating, swelling relieving and stasis removing are achieved, blood circulation is improved, brain blood supplying is promoted, and therefore the effect of treating cervical spondylosis is achieved. The medicine cake has the advantages of being low in making cost, convenient to use, good in treating effect and free of side effect.
Owner:邱定武

Thromboembolism agent, storage and releasing device thereof

A vascular blocker for effectively cutting off the blood supplying channel to target tissue is a gas-state substance which is CO2 or the mixture of CO2 and O2 able to be absorbed by blood. Its storage and release equipment is also disclosed. Its advantages are no hypersensitivity, no kidney poisoning, and high blocking effect.
Owner:董永华

Preparation method of magnetic guiding anticancer medicine

InactiveCN1493360APowder deliveryEnergy modified materialsSide effectBlood/plasma substitute
A magnetically pilotted anticancer medicine is prepared by adding the magnetic Fe-C attachment to the medium containing the blood plasma substitute and anticancer medicine. Under the monitor of angiography, said medicine can be pilotted magnetically in the blood supplying artery of tumor to form thrombus in the blood vessels around the tumor, so fully playing the role of anticancer medicine.
Owner:DEZHOU KELONG CARRIER INST

Magnet therapy paster for treating tumor and manufacturing method of magnet therapy paster

The invention relates to the field of medical treatment, in particular to a magnet therapy paster for treating the tumor. The magnet therapy paster is composed of a paster body comprising a medical adhesive tape adhering layer and a protection layer, a magnet therapy layer made of magnetic materials and a viscosity agent, and the like, and has different magnetic field intensities, different shapes and different specifications and models. The magnet therapy paster has the functions of restraining tumor tissue blood supplying and metabolism, changing cancer cell forms, inducing tumor cell apoptosis, restraining tumor growth, enabling the tumor to gradually become smaller, eliminating the inflammation of the vascular wall, reducing pain signal transmission, controlling middle and late period cancer diffusion and pains, improving local microcirculation and immunity and not hurting the benign adjustment of the normal cells. When the magnet therapy paster is used, the specifications and models are selected according to the ages, the states of illness and the nidus positions, the protection layer is uncovered, the magnet therapy layer and the adhering layer in the paster body tightly adhere to the channel and collateral skin in the nidus area and related shu-acupoint or Shenque acupoint, a plurality of pasters can be used at different positions at the same time, and the paster is replaced every one to two days.
Owner:罗世琴

Paste form external use medicine for treating headache and its preparation

The externally applied medicine ointment for treating headache is prepared with red lady-bug, cantharides, dahurian angelica root, cape jasmine, croton, cinnabar, realgar, musk and honey in certain proportion, and through stoving, crushing, grinding into 100-200 mesh, mixing and bottling. The present invention has no damage to internal organs, can stop pain and improve the cerebral vascular blood supplying and oxygen supplying state, and has no any toxic side effect.
Owner:钟亚彬
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products